CY2016054I1 - Κιναση της θυμιδινης - Google Patents

Κιναση της θυμιδινης

Info

Publication number
CY2016054I1
CY2016054I1 CY2016054C CY2016054C CY2016054I1 CY 2016054 I1 CY2016054 I1 CY 2016054I1 CY 2016054 C CY2016054 C CY 2016054C CY 2016054 C CY2016054 C CY 2016054C CY 2016054 I1 CY2016054 I1 CY 2016054I1
Authority
CY
Cyprus
Prior art keywords
kinesis
thymidine
thymidine kinesis
Prior art date
Application number
CY2016054C
Other languages
English (en)
Other versions
CY2016054I2 (el
Original Assignee
Molmed Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Molmed Spa filed Critical Molmed Spa
Publication of CY2016054I1 publication Critical patent/CY2016054I1/el
Publication of CY2016054I2 publication Critical patent/CY2016054I2/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • A61K48/0058—Nucleic acids adapted for tissue specific expression, e.g. having tissue specific promoters as part of a contruct
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • C12N9/1211—Thymidine kinase (2.7.1.21)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Vascular Medicine (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
CY2016054C 2004-06-18 2016-12-28 Κιναση της θυμιδινης CY2016054I2 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0413702.2A GB0413702D0 (en) 2004-06-18 2004-06-18 Thymidine kinase
PCT/IB2005/002358 WO2005123912A2 (en) 2004-06-18 2005-06-17 Thymidine kinase

Publications (2)

Publication Number Publication Date
CY2016054I1 true CY2016054I1 (el) 2017-07-12
CY2016054I2 CY2016054I2 (el) 2017-07-12

Family

ID=32750189

Family Applications (2)

Application Number Title Priority Date Filing Date
CY20111100964T CY1111925T1 (el) 2004-06-18 2011-10-10 Κιναση της θυμιδινης
CY2016054C CY2016054I2 (el) 2004-06-18 2016-12-28 Κιναση της θυμιδινης

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CY20111100964T CY1111925T1 (el) 2004-06-18 2011-10-10 Κιναση της θυμιδινης

Country Status (21)

Country Link
US (5) US8357788B2 (el)
EP (1) EP1781789B1 (el)
JP (1) JP5091669B2 (el)
KR (1) KR101337210B1 (el)
CN (1) CN101010428B (el)
AT (1) ATE520779T1 (el)
AU (1) AU2005254807B2 (el)
CA (1) CA2569304C (el)
CY (2) CY1111925T1 (el)
DK (1) DK1781789T3 (el)
ES (1) ES2372022T3 (el)
GB (1) GB0413702D0 (el)
HK (1) HK1097881A1 (el)
HU (1) HUS1600064I1 (el)
IL (2) IL179660A (el)
LT (1) LTC1781789I2 (el)
NL (1) NL300856I2 (el)
PL (1) PL1781789T3 (el)
PT (1) PT1781789E (el)
SI (1) SI1781789T1 (el)
WO (1) WO2005123912A2 (el)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0413702D0 (en) 2004-06-18 2004-07-21 Molmed Spa Thymidine kinase
EP2764094A1 (en) 2011-10-05 2014-08-13 MolMed SpA Viral vectors purification system
EP3733854A4 (en) * 2017-12-28 2021-12-01 Bionoxx Inc. ONCOLYTIC VIRUS WITH IMPROVED SECURITY AND ANTI-CANCER EFFECT
US11157042B1 (en) 2018-03-28 2021-10-26 Douglas Patton Systems and methods for interaction of wearable communication devices
KR20210016567A (ko) 2018-05-30 2021-02-16 글리코스템 떼라퓨틱스 비.브이. Car nk 세포
US20220202885A1 (en) * 2019-06-27 2022-06-30 Bionoxx Inc. Oncolytic virus with improved safety and anticancer effects

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE219519T1 (de) * 1989-01-23 2002-07-15 Chiron Corp Rekombinanttherapien für infektionen und hyperproliferative störungen
EP0454781B1 (en) 1989-01-23 1998-12-16 Chiron Corporation Recombinant cells for therapies of infection and hyperproliferative disorders and preparation thereof
US5631236A (en) * 1993-08-26 1997-05-20 Baylor College Of Medicine Gene therapy for solid tumors, using a DNA sequence encoding HSV-Tk or VZV-Tk
IT1261847B (it) 1993-09-01 1996-06-03 San Romanello Centro Fond Metodo per marcare cellule eucariote.
FR2712603B1 (fr) 1993-11-18 1996-02-09 Centre Nat Rech Scient Virus recombinants, préparation et utilisation en thérapie génique.
AU2434195A (en) 1994-05-02 1995-11-29 University Of Washington Thymidine kinase mutants
EP0879288A1 (fr) * 1996-02-09 1998-11-25 Aventis Pharma S.A. Variants de la thymidine kinase, sequences d'acides nucleiques correspondantes et leur utilisation en therapie genique
FR2744731B1 (fr) 1996-02-09 1998-05-22 Rhone Poulenc Rorer Sa Nouveaux variants de la thymidine kinase, sequences d'acides nucleiques correspondantes et leur utilisation en therapie genique
FR2751988B1 (fr) 1996-08-01 1998-09-11 Rhone Poulenc Rorer Sa Nouveaux variants de la thymidine kinase, sequences d'acides nucleiques correspondantes et leur utilisation en therapie genique
WO1997037542A1 (en) 1996-04-10 1997-10-16 University Of Southern California Gene therapy for proliferative vitreoretinopathy
EP2298350A3 (en) 1996-07-26 2011-06-08 Susan P. Perrine Composition comprising an inducing agent and an anti-viral agent for the treatment of viral disorders
JP2002516061A (ja) 1997-10-14 2002-06-04 ダーウィン モレキュラー コーポレイション チミジンキナーゼ変異体ならびにチミジンキナーゼ活性およびグアニル酸キナーゼ活性を有する融合タンパク質
GB0008966D0 (en) * 2000-04-13 2000-05-31 Imp College Innovations Ltd Vectors for gene therapy
CN1273587C (zh) * 2002-06-05 2006-09-06 上海新世界基因技术开发有限公司 疱疹病毒胸苷激酶突变体及其应用
DE50213745D1 (de) * 2002-12-09 2009-09-17 Celltech Gmbh Biotechnologie Verbesserte retrovirale Vektoren für die Gentherapie
GB0413702D0 (en) 2004-06-18 2004-07-21 Molmed Spa Thymidine kinase

Also Published As

Publication number Publication date
EP1781789B1 (en) 2011-08-17
AU2005254807A1 (en) 2005-12-29
CN101010428B (zh) 2013-10-02
CA2569304C (en) 2014-08-12
GB0413702D0 (en) 2004-07-21
CY1111925T1 (el) 2015-11-04
US20090130069A1 (en) 2009-05-21
JP2008502342A (ja) 2008-01-31
JP5091669B2 (ja) 2012-12-05
WO2005123912A3 (en) 2006-05-04
KR101337210B1 (ko) 2013-12-06
PT1781789E (pt) 2011-10-20
EP1781789A2 (en) 2007-05-09
US10155052B2 (en) 2018-12-18
KR20070032786A (ko) 2007-03-22
SI1781789T1 (sl) 2012-03-30
US20140178345A1 (en) 2014-06-26
WO2005123912A2 (en) 2005-12-29
DK1781789T3 (da) 2011-11-28
IL179660A (en) 2012-12-31
IL179660A0 (en) 2007-05-15
ES2372022T3 (es) 2012-01-13
US20150231275A1 (en) 2015-08-20
PL1781789T3 (pl) 2011-12-30
US20190070312A1 (en) 2019-03-07
US20130028876A1 (en) 2013-01-31
HK1097881A1 (en) 2007-07-06
US10314925B2 (en) 2019-06-11
ATE520779T1 (de) 2011-09-15
LTPA2016047I1 (lt) 2017-01-25
IL213084A0 (en) 2011-07-31
CN101010428A (zh) 2007-08-01
US9005945B2 (en) 2015-04-14
NL300856I2 (el) 2017-04-20
US8642311B2 (en) 2014-02-04
LTC1781789I2 (lt) 2018-10-10
HUS1600064I1 (hu) 2017-02-28
CY2016054I2 (el) 2017-07-12
US8357788B2 (en) 2013-01-22
CA2569304A1 (en) 2005-12-29
AU2005254807B2 (en) 2011-08-18

Similar Documents

Publication Publication Date Title
CY2019034I1 (el) 4-φαινυλαμινο-κιναζολιν-6-υλ-αμιδια
DE602005000270D1 (de) Regelungssystem
DE602005016675D1 (de) Bussteuerung
DK1928882T3 (da) (s)-n-methylnaltrexon
DK1683933T3 (da) Betjeningsgreb
DK1836211T3 (da) Makrolider
ATE520680T1 (de) Hiv-hemmende 5-heterocyclylpyrimidine
NO20043980D0 (no) Boyestiver
CY2016054I1 (el) Κιναση της θυμιδινης
DE112005000809A5 (de) Wankstabilisierungseinrichtung
DE602006000836D1 (de) Leitungssteuerungsanordnung
DE502006007182D1 (de) Steuergerät
DE602004011999D1 (de) Mehrbenutzer-übertragungssystem
DE602005027790D1 (de) Bussteuerung
DK1968623T3 (da) Bacteriocin-inducer-peptider
DE502005005858D1 (de) Steuer- und Regeleinheit
AT500198B1 (de) Ladewagen
DE602004027003D1 (de) Ausziehbohle
ATE389633T1 (de) Omega-phenyloctanamide
DE112005000794T5 (de) Urethanspritzpistolenanordnung
AT500249A3 (de) Scheibenegge
DE502004005570D1 (de) Mousepad
DE502004010807D1 (de) Auftragskopf
ITMI20050088A1 (it) Paratia
DE112005001019A5 (de) Kunststoffschraubverschlusskappe